VIAD PHARMA ApS: Financial statements 2021
CVR: 36433892
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,048,036 and a net result of DKK 250,426 compared with DKK 457,510 the year before. That is a decrease of 18.8% compared with the year before. Equity in the 2021 report amounted to DKK 318,793. The solvency ratio was 16%.
- Gross Profit
- DKK 1,048,036
- Profit/Loss
- DKK 250,426
- Equity
- DKK 318,793
- Total Assets
- DKK 1,988,241
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1 mio. | 250 t. | 319 t. | - |
| 2020 | - | 1.3 mio. | 458 t. | 526 t. | - |
| 2019 | - | 1.4 mio. | 555 t. | 668 t. | - |
| 2018 | - | 1.4 mio. | 553 t. | 714 t. | - |
| 2017 | - | 1.5 mio. | 677 t. | 761 t. | - |
Official annual report
Find more companies like VIAD PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
VIAD PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 1,290,916, and the net result was DKK 457,510.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.